Sami Joha

RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL+ leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance

Catherine Roche‐Lestienne, Lauréline Deluche, Sélim Corm et al. · Blood · 2008 · 72 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Exploiting Mitochondrial Dysfunction for Effective Elimination of Imatinib-Resistant Leukemic Cells

Jérôme Kluza, Manel Jendoubi, Caroline Ballot et al. · PLoS ONE · 2011 · 66 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Activity of elaeochytrin A from Ferula elaeochytris on leukemia cell lines

Racha Alkhatib, Thierry Hennebelle, Sami Joha et al. · Phytochemistry · 2008 · 49 citations

Medicine, Oncology, Pharmacology +3

BCR-ABL mutants spread resistance to non-mutated cells through a paracrine mechanism

J Liu, Sami Joha, Thierry Idziorek et al. · Leukemia · 2008 · 47 citations

Life Sciences, Molecular Biology, Oncology +12

GILZ inhibits the mTORC2/AKT pathway in BCR-ABL+ cells

Sami Joha, A-L Nugues, Dominique Hétuin et al. · Oncogene · 2011 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17